CSIMarket
 
Nephros Inc   (NASDAQ: NEPH)
 

Nephros Inc's Suppliers Performance

NEPH's Supply Chain




 
NEPH Costs vs Sales of Suppliers Growth Nephros Inc recorded an increase in cost of sales by 99.1 % year on year, relative to one quarter ago cost of sales fell by -0.45 % in Q2.

• More on NEPH Suppliers



Nephros Inc recorded increase in cost of sales by 99.1 % year on year, compare to one quarter ago cost of sales fell by -0.45 % in Q2.

• More on NEPH Suppliers




Nephros Inc's Comment on Supply Chain


The company manufactures some commercial filtration products at its South Orange, New Jersey facility but does not manufacture its medical device filtration products. It holds a License and Supply Agreement with Medica S.p.A., an Italy-based medical product manufacturer, granting the company exclusive rights to market, sell, and supply filtration products based on Medica's Medisulfone ultrafiltration and Versatile microfiber technologies. This agreement, extended in November 2025 through December 31, 2030, obligates the company to make minimum annual purchases from Medica ranging from €4,976,000 in 2026 to €6,300,000 in 2030. The agreement includes provisions for interest on overdue invoices and termination conditions for either party. The company's New Jersey headquarters oversees global sales and marketing, collaborating with multiple distributors in hospital and dialysis water markets. Donastar LLC served as the exclusive distributor for foodservice and hospitality markets until September 2024, after which the distribution arrangement became non-exclusive to expand market reach.

Nephros Inc's Comment on Supply Chain


The company manufactures some commercial filtration products at its South Orange, New Jersey facility but does not manufacture its medical device filtration products. It holds a License and Supply Agreement with Medica S.p.A., an Italy-based medical product manufacturer, granting the company exclusive rights to market, sell, and supply filtration products based on Medica's Medisulfone ultrafiltration and Versatile microfiber technologies. This agreement, extended in November 2025 through December 31, 2030, obligates the company to make minimum annual purchases from Medica ranging from €4,976,000 in 2026 to €6,300,000 in 2030. The agreement includes provisions for interest on overdue invoices and termination conditions for either party. The company's New Jersey headquarters oversees global sales and marketing, collaborating with multiple distributors in hospital and dialysis water markets. Donastar LLC served as the exclusive distributor for foodservice and hospitality markets until September 2024, after which the distribution arrangement became non-exclusive to expand market reach.







NEPH's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Nephros Inc 47.01 21.69 1.74 36
SUBTOTAL 0.00 0.00 0.00 -


Sources: Nephros Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Nephros Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.